Accessibility Menu
 
Sartorius Aktiengesellschaft logo

Sartorius Aktiengesellschaft

(ETR) SRT3

Current Price$215.50
Market Cap$14.88B
Since IPO (1999)+644%
5 Year-50%
1 Year-2%
1 Month-8%

Sartorius Aktiengesellschaft Financials at a Glance

Market Cap

$14.88B

Revenue (TTM)

$3.54B

Net Income (TTM)

$155.00M

EPS (TTM)

$2.25

P/E Ratio

95.99

Dividend

$0.74

Beta (Volatility)

-0.05 (Low)

Price

$215.50

Volume

78,873

Open

$210.00

Previous Close

$215.50

Daily Range

$209.70 - $217.20

52-Week Range

$166.05 - $267.70

SRT3 News

No articles available.

SRT3: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sartorius Aktiengesellschaft

Industry

Life Sciences Tools and Services

Employees

14,042

CEO

Michael Grosse, PhD

Headquarters

Göttingen, 37079, DE

SRT3 Financials

Key Financial Metrics (TTM)

Gross Margin

46%

Operating Margin

16%

Net Income Margin

4%

Return on Equity

6%

Return on Capital

7%

Return on Assets

2%

Earnings Yield

1.04%

Dividend Yield

0.00%

Payout Ratio

32.71%

Stock Overview

Market Cap

$14.88B

Shares Outstanding

69.05M

Volume

78.87K

Short Interest

0.00%

Avg. Volume

99.72K

Financials (TTM)

Gross Profit

$1.64B

Operating Income

$651.40M

EBITDA

$1.07B

Operating Cash Flow

$656.00M

Capital Expenditure

$441.90M

Free Cash Flow

$214.10M

Cash & ST Invst.

$541.40M

Total Debt

$4.45B

Sartorius Aktiengesellschaft Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$927.60M

+2.3%

Gross Profit

$396.40M

+0.5%

Gross Margin

42.73%

N/A

Market Cap

$14.88B

N/A

Market Cap/Employee

$1.10M

N/A

Employees

13,573

N/A

Net Income

$30.20M

-32.0%

EBITDA

$267.20M

+79.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$3.91B

-4.9%

Accounts Receivable

$291.70M

-25.4%

Inventory

$792.20M

+0.5%

Long Term Debt

$3.53B

-15.3%

Short Term Debt

$926.40M

+135.7%

Return on Assets

1.60%

N/A

Return on Invested Capital

7.40%

N/A

Free Cash Flow

$170.90M

-37.3%

Operating Cash Flow

$307.80M

-15.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GE9.FGenmab A/S
$226.40+0.62%
ILU.DEIllumina, Inc.
$109.00+0.76%
CBHD.DEColoplast A/S
$58.10+1.04%
FME.DEFresenius Medical Care AG & Co. KGaA
$38.94+1.41%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
EEIQEpicQuest Education Group International
$8.44+2.09%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.92+0.08%
INTCIntel
$44.10-0.07%

Questions About SRT3

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.